Ad is loading...
AAVXF
Price
$11.05
Change
-$4.10 (-27.06%)
Updated
Jul 30 closing price
ACHV
Price
$4.52
Change
+$0.03 (+0.67%)
Updated
Dec 6 closing price
95 days until earnings call
Ad is loading...

AAVXF vs ACHV

Header iconAAVXF vs ACHV Comparison
Open Charts AAVXF vs ACHVBanner chart's image
Abivax SA
Price$11.05
Change-$4.10 (-27.06%)
Volume$1K
CapitalizationN/A
Achieve Life Sciences
Price$4.52
Change+$0.03 (+0.67%)
Volume$75.23K
CapitalizationN/A
AAVXF vs ACHV Comparison Chart
Loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AAVXF vs. ACHV commentary
Dec 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAVXF is a Buy and ACHV is a StrongSell.

COMPARISON
Comparison
Dec 09, 2024
Stock price -- (AAVXF: $11.05 vs. ACHV: $4.52)
Brand notoriety: AAVXF and ACHV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AAVXF: 100% vs. ACHV: 67%
Market capitalization -- AAVXF: $509.88M vs. ACHV: $154.41M
AAVXF [@Biotechnology] is valued at $509.88M. ACHV’s [@Biotechnology] market capitalization is $154.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $489.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AAVXF’s FA Score shows that 0 FA rating(s) are green whileACHV’s FA Score has 0 green FA rating(s).

  • AAVXF’s FA Score: 0 green, 5 red.
  • ACHV’s FA Score: 0 green, 5 red.
According to our system of comparison, ACHV is a better buy in the long-term than AAVXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 4 TA indicator(s) are bullish.

  • ACHV’s TA Score: 4 bullish, 6 bearish.

Price Growth

AAVXF (@Biotechnology) experienced а 0.00% price change this week, while ACHV (@Biotechnology) price change was +2.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -2.68%, and the average quarterly price growth was +10.76%.

Reported Earning Dates

ACHV is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AAVXF($510M) has a higher market cap than ACHV($154M). ACHV YTD gains are higher at: 9.709 vs. AAVXF (8.440).
AAVXFACHVAAVXF / ACHV
Capitalization510M154M331%
EBITDAN/A-29.95M-
Gain YTD8.4409.70987%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A42.9M-
Total DebtN/A9.85M-
FUNDAMENTALS RATINGS
AAVXF vs ACHV: Fundamental Ratings
AAVXF
ACHV
OUTLOOK RATING
1..100
5061
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
63
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
7462
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AAVXF's Valuation (60) in the null industry is in the same range as ACHV (63) in the Biotechnology industry. This means that AAVXF’s stock grew similarly to ACHV’s over the last 12 months.

AAVXF's Profit vs Risk Rating (100) in the null industry is in the same range as ACHV (100) in the Biotechnology industry. This means that AAVXF’s stock grew similarly to ACHV’s over the last 12 months.

AAVXF's SMR Rating (98) in the null industry is in the same range as ACHV (99) in the Biotechnology industry. This means that AAVXF’s stock grew similarly to ACHV’s over the last 12 months.

ACHV's Price Growth Rating (62) in the Biotechnology industry is in the same range as AAVXF (74) in the null industry. This means that ACHV’s stock grew similarly to AAVXF’s over the last 12 months.

ACHV's P/E Growth Rating (100) in the Biotechnology industry is in the same range as AAVXF (100) in the null industry. This means that ACHV’s stock grew similarly to AAVXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AAVXFACHV
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
84%
Stochastic
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
75%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
33%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
29%
Bearish Trend 3 days ago
82%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OLYMY15.880.37
+2.39%
Olympus Corp.
SKFRY20.310.24
+1.20%
AB SKF
SMMNY27.15-0.11
-0.40%
Siemens Healthineers AG
PEMIF0.21-0.01
-3.06%
Pure Energy Minerals Ltd.
BRCHF0.15-0.01
-3.89%
Brainchip Holdings Ltd.

AAVXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AAVXF has been loosely correlated with BPMUF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AAVXF jumps, then BPMUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AAVXF
1D Price
Change %
AAVXF100%
N/A
BPMUF - AAVXF
47%
Loosely correlated
N/A
MLEC - AAVXF
38%
Loosely correlated
-0.07%
CNSP - AAVXF
34%
Loosely correlated
-1.26%
ACHV - AAVXF
28%
Poorly correlated
+0.67%
RENB - AAVXF
26%
Poorly correlated
+22.92%
More